Business · 08/10/2002Updated: 10/17/2026 · 1 min read
FDA Announces Approval of OMB for Long-Term Antibiotic Therapy Evaluation
Summary
The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) for a collection of information related to the evaluation of long-term antibiotic therapy for individuals involved in anthrax remediation efforts, as mandated by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →